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1. Introduction 
Pervasive Developmental Disorders (PDD), also called Autism Spectrum Disorders (ASD), 
are defined in terms of abnormalities in social and communication development in the 
presence of marked repetitive behaviour and narrow interests (APA, 1994). The DSM-IV 
(APA, 1994) and ICD-10 (WHO, 1993) provide diagnostic criteria for autism and related 
disorders such as Asperger syndrome (AS), Rett’s, and childhood disintegrative disorder. 
Unfortunately, the diagnostic category of pervasive development disorder-not otherwise 
specified (PDD-NOS) does not have specific criteria and is often seen as a catchall diagnosis 
for children who do not fit the criteria for one of the other pervasive developmental 
disorders (Filipek et al., 1999).   
According to Cohen & Volkmar (2005) classification systems should aim at improving 
communication, through their features (internal consistency, use easiness, good definition of 
categories) and being widely accepted. The accuracy of early diagnosis, as well as 
developmental pathways that are observed in young children with ASD have both 
theoretical and practical importance (Luyster et al., 2005). An empirically developed 
dimensional approach that defines the spectrum on multiple dimensions may offer several 
advantages. It may, for example, result in more correspondence between the results of 
genetic research and the phenotype of autistic disorders, provided the pathology can be 
summarized by empirical and valid behavior dimensions (Volkmar et al., 2004; van Lang et 
al., 2006; Hus et al., 2007).  
It is now well recognized that children with PDD vary in the number and severity of 
symptoms (Szatmari et al., 2002). In DSM-IV, a diagnostic category within PDD, which is 
called “pervasive developmental disorder-not otherwise specified” (PDD-NOS), defines 
children with symptoms such as restricted social interaction, poor verbal and non-verbal 
communication skills, strict and/or stereotypical behaviors but without full diagnostic 
criteria of autism (APA, 1994). Epidemiological data suggest that PDD-NOS is at least twice 
as common as autism in the general community (Chakrabatri & Fombonne, 2001). One or 
more of the following conditions may lead to a PDD-NOS diagnosis (1) onset of the disorder 
after 3 years of age, (2) atypical symptoms with regard to the 12 criteria of autism specified 
in DSM-IV, (3) fewer than 6 criteria and thus subtreshold (Walker et al., 2004). A categorical 
system like DSM-IV can be very useful for diagnosing prototypic manifestations of a 
disorder, but it is less useful in encompassing what may be, in its broader manifestations, a 
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“spectrum disorder” (Tanguay, 2004). An assumption of the autism-spectrum model is that 
autism conditions lie on a continuum of social-communication skills (Baron-Cohen et al., 
2001; Wakabayashi et al., 2007). A continuum view shifts us away from categorical diagnosis 
and towards a quantitative approach. 
Diagnostic agreement for PDD-NOS is generally considered to be weak (Tanguay, 2004). 
Walker and colleagues presented compelling evidence, both from the literature and from 
their study, that attempting to improve the DSM-IV criteria for PDD-NOS can be quite 
frustrating (Walker et al., 2004). Many of the symptoms of PDD-NOS can occur in non-PDD 
conditions, such as severe mental retardation or language delay, and they may present with 
similar developmental history (Bishop et al., 2006). Furthermore, clinical presentation of 
PDD-NOS may resemble presenting symptoms in high functioning autism, Asperger’s 
disorder, reactive attachment disorder, and psychotic disorders, and the differential 
diagnosis may be highly complicated. 
Studies on the distinction between Autistic Disorder (AD) and Pervasive Developmental 
Disorder Not Otherwise Specified (PDD-NOS) have been inconclusive (Snow & Lecavalier, 
2011). The field is in need of more studies examining subtype differences. As the diagnostic 
validity of PDD-NOS is still open to question, and to explore proposed underlying factors, 
we have to assign cases based on a valid clinical assessment. Therefore, we still need to 
investigate further the clinical features of children with PDD-NOS that distinguish them 
from children with autism and other non-PDD conditions. 
2. Autism, PDD-NOS, and ADHD 
Barkley (1990) reported that it is common for children with PDD-NOS to be initially given a 
diagnosis of Attention Deficit/Hyperactivity Disorder (ADHD). Jensen et al., (1997) 
reported that 74% of the children in their study diagnosed with PDD-NOS were originally 
diagnosed with ADHD. Another study showed that children with PDD-NOS and ADHD 
did not differ from each other with respect to total number of autistic symptoms, general 
psychopathology, or attention difficulties (Luteijn et al., 2000). Methods for differentiating 
PDD-NOS from the non-PDD disorders, such as attention deficit hyperactivity disorder 
(ADHD), are not well established. Several investigators concluded that it is difficult to make 
a distinction between ADHD and PDD by using the present diagnostic criteria in DSM-IV 
(Bryson et al., 2008; Gökler et al., 2004). The characteristics that differentiated children with 
PDD-NOS from those with autism and non-PDD disorders were also explored by Buitelaar 
et al., (1999). Four criteria discriminated autism from PDD-NOS most effectively: children 
with autism more often demonstrated restricted patterns of interest, lacked varied make-
believe play, failed to use nonverbal behavior, and had an earlier age of onset. In another 
study (Allen et al., 2001), the PDD-NOS group (including both high- and low-functioning 
children) did not differ significantly from the autism or non-PDD groups on measures of 
language or adaptive functioning but did show less restricted stereotyped behaviors than 
the high-functioning autism group. 
In a very recent study (Snow & Lecavalier, 2011), authors examined the validity of PDD 
NOS by comparing it to autistic disorder (AD) and other developmental disorders (DD) 
on parent-reported behavior problems. Fifty-four children with PDD-NOS were 
individually matched on age and nonverbal IQ to 54 children with AD and 54 children 
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with DD. The only difference between PDD-NOS and AD groups was higher scores in the 
PDD-NOS group on two items measuring Anxiety/Depression. Cognitive functioning 
may be a more salient variable than subtype when studying psychopathology in 
individuals with ASDs. 
In a study (Karabekiroglu & Akbas, in press) designed to explore whether PDD-NOS 
encompassed a distinct cluster of symptoms and clinical profile or not, we investigated 
differential features of PDD-NOS such as presenting symptoms, developmental history, and 
comorbidity with respect to autism and ADHD. The study involved 188 children (PDD-NOS 
n=94; ADHD n=47; autism n=47) (male n=150, female n=38) who were 5.5(±2.5) years old on 
average (range 2-11 yrs.). The children with Asperger Syndrome were excluded. Preliminary 
PDD-NOS screening scale (PPSSS) was developed based on the ‘presenting’ symptoms of 
PDD-NOS that were systematically collected in a pilot group of children (Table 1).  
The clinical diagnoses and comorbidities were based on the comprehensive mental status 
examination, Schedule for Affective Disorders and Schizophrenia for School Age Children-
Present and Lifetime Version-Turkish Version (K-SADS-PL-T), and the consensus between 
two child and adolescent psychiatry specialists. The prevelance rates of the most common 
presenting symptoms in the PDD-NOS and autism groups showed a similar pattern of 
distribution from most common to the least (Figure 1), even when the results were corrected 
for age. However, almost all of these symptoms are reported significantly less in prevalence 
in the PDD-NOS group. 
In this study, ADHD was also explored as a co-morbid diagnosis; 38.3% of the children in 
the PDD-NOS group and 53.2% of the children with autism fullfilled ADHD criteria (p>.05). 
Compared with children in the PDD-NOS group, children in the ADHD group had 
significantly higher rates of co-morbid disruptive behavior disorders (27.6% vs. 9.6%), 
learning disorders (14.9% vs. 5.3%), elimination disorders (12.8% vs. 2.1%), tic disorders 
(8.5% vs. 2.1%), social anxiety disorder (8.5% vs. 2.1%) and lower rates of co-morbid 
obsessive compulsive disorder (2.1% vs. 23.4%). The rates of other co-morbid disorders, 
such as depression, language disorders, and sleep disorders, were found to be similar across 
diagnostic groups. The findings of this study reveal that the PDD-NOS group had a high 
number of features in common with the autism and the ADHD groups, in terms of 
presenting and/or reported symptoms and developmental history. Similar to previous 
studies (Volkmar, et al 1993), gender distribution was similar for all groups (in each group 
more than 75% of the patients were male). A recent study has suggested that approximately 
70% of children with ASDs have at least one comorbid psychiatric disorder (Simonoff et al., 
2008). The most prevalent comorbid disorders were anxiety disorders (42%), oppositional or 
conduct disorders (30%), and ADHD (28%). 
In our study (Karabekiroglu & Akbas, in press), as shown in Table 1 and Figure 1, the 
prevelance rates of the most common presenting symptoms in the PDD-NOS and autism 
groups had a similar pattern of distribution from more to less common. However, almost all 
of these symptoms were reported significantly less in children diagnosed with PDD-NOS 
than children with autism. The autism and the PDD-NOS shared a common clinical 
symptom profile on the first clinical admission. On the other hand, the children with ADHD 
had a distinct set of symptoms. The results suggest that PDD-NOS may be assumed as a 
quantitative partial subtype of autism, and it represents a less severe form that lies on a 
continuum of social-communication skills.  
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Preliminary PDD-NOS Symptom 
Screening Scale (PPSSS) Items  
 
Presence of the symptoms 
(percentages) 
  
PDD-
NOS 
(1) 
 
Autism
(2) 
 
ADHD
(3) 
 
Overall 
significan
ce 
(p value)
Source of 
significance 
 
1. poor social interaction 59.6 97.9 8.5 <.001 1:2; 1:3; 2:3 
2. hyperactivity 56.4 80.9 89.4 <.001 1:2; 1:3 
3. not speaking/ language 
retardation 
53.2 97.9 6.4 <.001 1:2; 1:3; 2:3 
4. aggressiveness  33.0 46.8 61.7 N.S.  
5. stubbornness 31.9 46.8 44.7 N.S.  
6. inattentiveness 30.9 66.0 91.5 <.001 1:2; 1:3; 2:3 
7. obsessions 29.8 27.7 14.9 N.S.  
8. not responsive to social stimuli 25.5 95.7 40.4 <.001 1:2; 2:3 
9. stereotypies 24.5 59.6 6.4 <.001 1:2; 1:3; 2:3 
10. impatience and/or 
impulsiveness 
23.4 48.9 78.7 <.001 1:2; 1:3; 2:3 
11. fastidiousness, choosyness 23.4 10.6 10.6 N.S.  
12. echolalia 22.3 14.9 - N.S.  
13. highly interested in television 20.2 46.8 17.0 <.001 1:2; 2:3 
14. conduct problems 21.3 36.2 40.4 N.S.  
15. articulation and/or prosody 
problems  
18.1 8.5 4.3 N.S.  
16. lack of eye contact 14.9 59.6 - <.001 1:2; 1:3; 2:3 
17. multiple fears 14.9 8.5 17.0 N.S.  
18. sleep problems 14.9 10.6 27.7 N.S.  
19. tactile oversensitivity 12.8 25.5 6.4 N.S.  
20. confusing pronouns 11.7 12.8 - N.S.  
21. shyness 11.7 6.4 17.0 N.S.  
22. emotional lability 11.7 - 27.7 <.001 1:3; 2:3 
23. tics 10.6 4.3 10.6 N.S.  
24. poor appetite 7.4 25.5 21.3 N.S.  
25. inappropriate laughing 4.3 17.0 2.1 N.S.  
26. persistence with sameness 2.1 12.8 6.4 N.S.  
27. frequent startles 1.1 10.6 8.5 N.S.  
Table 1. Preliminary PDD-NOS Symptom Screening Scale (PPSSS) item distributions of 
patients in each diagnosis group  
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Fig. 1. The significantly discriminative symptom percentages of the diagnostic groups 
3. Cluster and factor analysis 
To identify ASD subgroups, several investigators used cluster and factor analysis based on 
social functioning, intelligence, developmental milestones, and so forth. Various clusters 
were reported (Eaves et al., 1994; Prior et al., 1998; Sevin et al., 1995; Waterhouse et al., 1996; 
Wing & Gould, 1979). But these findings were not replicated and the clusters identified were 
not adopted or replicated in later studies. Despite several studies with ASD, clinical validity 
and differential features of PDD-NOS are yet to be consistently established. A very recent 
study (Shumway et al., 2011) examined the relationship between onset status and current 
functioning using a recently proposed onset classification system in 272 young children with 
autism spectrum disorder (ASD). Participants were classified into one of the following 
groups, based on parent report using the Autism Diagnostic Interview—Revised: Early 
Onset (symptoms by 12 months, no loss), Delay and Regression (symptoms by 12 months 
plus loss), Plateau (no early symptoms or loss), and Regression (no early symptoms, 
followed by loss). Findings indicate that current functioning does not differ according to 
onset pattern, calling into question the use of onset categorizations for prognostic purposes 
in children with ASD.  
A previous study performed a factor analysis on a sample of variant categories of PDD, and 
two factors emerged. One factor represented autistic symptoms and another represented 
level of functioning (Szatmari et al., 2002). More recent studies used a factor analytic 
approach based on particular diagnostic instruments, such as the Autism Diagnostic 
Interview-Revised (ADI-R) and the Autism Diagnostic Observation Schedule (ADOS) 
(Tadevosyan-Layfer et al., 2003; Tanguay, 2004). The results suggested that there is a 
developmental continuum from affective reciprocity to emotional joint attention to verbal 
joint attention and to intuitive social knowledge (Tanguay, 2004). Tadevosyan-Layfer et al. 
(2003) found six factors: spoken language, compulsions, developmental milestones, savant 
skills, sensory aversion, and social intent. 
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In our study (Karabekiroglu & Akbas, in press), including all subjects in all diagnostic 
groups (PDD-NOS n=94; ADHD n=47; autism n=47) (male n=150, female n=38) who were 
5.5(±2.5) years old on average (range 2-11 yrs.), a principal axis factor analysis with Promax 
rotation revealed ten factors; seven were found to be discriminative (Table 2, Figure 2). We 
 
 
Note. Loadings <.30 are omitted. Adopted items into the factors are shown bold.  
Table 2. PPSSS items and factor loadings for the rotated ten factors 
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 retained all components with eigenvalue (a measure of explained variance) greater than 
unity. Ten factors had eigenvalues greater than 1.0, which is a common criterion for a factor 
to be useful. When ten factors were requested, Kaiser-Meyer-OIkin (KMO) measure was 
adequate (.66), and Bartlett’s Test of Spherity was significant (p<.001). These measures mean 
that the variables are correlated highly enough to provide a reasonable basis for factor 
analysis. We considered all variables with factor loadings 0.3 or larger in the appropriate 
factor matrices to define the underlying factor and we took these variables as a cluster of 
variables for the factor. The two rotation procedures produced similar results. When there 
were differences, we took the Promax solution as the preferred one. After rotation, ten 
factors accounted for 66.3% of the variance. 
 
 
Factor 1 includes “lack of eye contact”, “stereotypies”, “inappropriate laughing”, “frequent startles”, 
“highly interestedness in TV”, and “tactile oversensitiveness”;  
Factor 2 includes “poor social interaction”, “language retardation”, and “not responsive”  
Factor 3 includes “inattentiveness”, “hyperactivity”, and “impatiente, impulsiveness” 
Factor 4 includes “aggressiveness” and “conduct problems” 
Factor 5 includes “confusing pronouns”, “echolalia”, and “articulation/ prosody problems” 
Factor 7 includes “fastidiousness, choosiness” and “obsessions” 
Factor 8 includes “poor appetite”, “stubbornness”, and “persistence with sameness” 
Fig. 2. The significantly discriminative factors of the diagnostic groups. 
We found significant differences in the toal number of symptoms between three diagnostic 
groups in the factors 1 (p<.001), 2 (p<.001), 3 (p<.001), 4 (p=.004), 5 (p<.001), 7 (p=.026), and 
8 (p=.006). The scores in the factors 1, 2, 3, and 8 were significantly higher in the autism 
group compared to the PDD-NOS group. The scores in the factors 1, 2, 5, and 7 were 
significantly higher in the PDD-NOS group compared to the ADHD group. Inversely, the 
scores in the factors 3, 4, and 8 were significantly higher in the ADHD group compared to 
the PDD-NOS group (Figure 2).  
www.intechopen.com
 
Autism Spectrum Disorders: The Role of Genetics in Diagnosis and Treatment 
 
24
Based on the assumption that the items were predicted to index three constructs: symptoms 
related to autism, ADHD, and PDD-NOS, in a further analysis three factors were requested 
(Karabekiroglu & Akbas, In press). The first factor seemed to index core autism spectrum, 
the second factor, disruptive behaviors spectrum, and the third factor seemed to index 
symptoms to be interpreted as anxiety spectrum. Four in twenty-seven items do not seem to 
load with any of the factors. When the total number of the symptoms in each factor were 
compared between the diagnostic groups, the core autism spectrum and the disruptive behavior 
spectrum factors revealed significant differences between the groups (p<.001). Post-hoc 
analysis showed that in the core autism spectrum factor, the autistic group had significantly 
more symptoms than the PDD-NOS group (4.87 vs. 2.14) (p<.001), and the PDD-NOS group 
had significantly more symptoms than the ADHD group (2.14 vs. 0.81) (p<.001). On the 
other hand, on the disruptive behavior spectrum factor, both the ADHD (3.62 vs. 2.19) (p<.001) 
and the autistic groups (4.55 vs. 2.19) (p<.001) had significantly more symptoms than the 
PDD-NOS group. The anxiety spectrum factor did not reveal a significant difference between 
diagnostic groups. 
4. Discussion 
Because the diagnostic agreement for PDD-NOS was generally considered to be weak 
(Tanguay 2004, Walker et al. 2004), and differentiation of PDD-NOS from the non-PDD 
disorders, such as ADHD was not well-defined, we conducted a factor analysis including 
the data from all three diagnosis groups (Autism, PDD-NOS, and ADHD) (Karabekiroglu & 
akbas, in press). A factor analysis revealed three symptom clusters, core autistic spectrum, 
disruptive behavior spectrum, and anxiety spectrum. As would be expected, the children with 
autism had higher rates of symptoms in the autistic spectrum factor and the children with 
ADHD had higher rates of symptoms in the disruptive behavior spectrum factor. The PDD-
NOS group had lower rates of symptoms on both factors. 
In a recent study (Kamp-Becker et al., 2009), the dimensional structure of higher functioning 
autism phenotype was investigated by factor analysis. The goal of this study was to identify 
the degree to which early symptoms of autism (measured using the ADI-R) could be 
predictive of the current symptoms of autism as identified using the ADOS, the adaptive 
behavior scales, IQ scores and theory of mind scores. The authors reported that the social 
interaction and communication domains were closely related to one factor namely: Social 
communication. An additional factor implies anxious and compulsive behavior which is 
associated with current social communication functioning. Another study compared the 
behavioral symptomatology in 26 children and adolescents with autism and 25 children and 
adolescents with PDD-NOS (Pearson et al., 2006). Relative to individuals with PDD-NOS, 
those with autism had more symptoms of depression, social withdrawal, atypical behavior, 
and immature social skills, and fewer family problems. These differences remained even 
when group differences in intellectual ability were controlled statistically. No group 
differences emerged in somatization, anxiety, or hyperactivity. Their findings suggested 
that, although both groups demonstrated considerable evidence of behavioral and 
emotional problems, those with autism were at particularly high risk for co-morbid 
behavioral and emotional disabilities (Pearson et al., 2006). 
In a recent study (Mandy et al., 2011) authors aimed, first, to improve the reliability and 
replicability of PDD-NOS by operationalizing its DSM-IV-TR description and, second, to test 
its validity through comparison with autistic disorder (AD) and Asperger’s disorder (AsD). 
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In a sample of 256 young people (mean age: 9.1 years) [AD (n:97), AsD (n:93) and PDD-NOS 
(n:66)], groups were compared on independent measures of core PDD symptomatology, 
associated autistic features, and intelligence. Contrary to the assumption that PDD-NOS is 
heterogeneous, almost all (97%) of those with PDD-NOS had one distinct symptom pattern, 
namely impairments in social reciprocity and communication, without significant repetitive 
and stereotyped behaviors (RSB). Compared to AD and AsD, they had comparably severe 
but more circumscribed social communication difficulties, with fewer non-social features of 
autism, such as sensory, feeding and visuo-spatial problems. These individuals appear to 
have a distinct variant of autism that does not merely sit at the less severe end of the same 
continuum of symptoms.  
The symptoms of ASD may change with development (Luyster et al., 2005). PDD-NOS has 
been assumed significantly less stable as a diagnosis (Lord et al., 2006). In a study (Kleinman 
et al., 2008), 77 children received a diagnostic and developmental evaluation between 16 and 
35 months and also between 42 and 82 months. Diagnoses based on clinical judgment, 
Childhood Autism Rating Scale, and the Autism Diagnostic Observation Schedule were 
stable over time. Diagnoses made using the Autism Diagnostic Interview were slightly less 
stable. According to clinical judgment, 15 children (19%) moved off the autism spectrum by 
the second evaluation; none moved onto the spectrum. Results indicate diagnostic stability 
at acceptable levels for diagnoses made at age 2. Nevertheless, diagnoses of autism and 
PDD-NOS by experienced clinicians on the basis of multiple measures were valid and 
reliable over time (Lord et al., 2006). If a child is given an ASD diagnosis (either autism or 
PDD-NOS) at age 2 years, it is highly likely to apply at age 9, although there may be some 
shifting within the range of ASD diagnostic categories (Lord et al., 2006). Generally, it 
appears that the overall picture of development for autism and PDD-NOS is similar, with 
most children experiencing continued impairment. Based on these two studies, there does 
not appear to be evidence for qualitatively discrete groups (i.e., autism versus PDD-NOS), 
but differences appear to be quantitative (Lord et al., 2006; Turner, et al., 2006).  
A recent meta-analysis (Rondeau et al., 2010) conducted on the eight longitudinal studies on 
PDD-NOS that have been published from 1996 to 2009 showed that PDD-NOS diagnosis 
was less stable than autistic disorder diagnosis. When established before 36 months, the 
overall stability rate was 35% at 3-year follow-up. Consistent with the previous literature on 
the reliability of the PDD-NOS diagnosis in young children, our metaanalysis did not 
support the discriminant and predictive validity of this category. Thus, from a clinical 
standpoint, children whose PDD-NOS diagnosis was established before 36 months should 
be re-assessed at a later age (Rondeau et al., 2010). 
Similar to previous reports (Allen et al., 2001, deBruin et al., 2006, Matson, et al., 2007, 
Szatmari et al. 2002), in our study (Karabekiroglu & Akbas, in press) mental retardation was 
significantly more prevalent in the autism than in the PDD-NOS or ADHD groups. Several 
investigators suggested that exploring the presence of mental retardation may be more 
useful in terms of planning treatment and predicting outcome than a classification based on 
symptom number alone (Szatmari et al., 2002). However, IQ may be a poor measure of level 
of functioning, based as it is on performance in a highly artificial setting (Szatmari et al. 
2002). In a study (Scheirs & Timmers, 2009) an attempt was made to distinguish among the 
three groups (ADHD, PDD-NOS, and ADHD plus PDD-NOS) on the basis of intelligence 
(WISC-III) profiles. It was found that the PDD-NOS group had higher verbal and 
performance IQ’s, as well as higher WISC-III index scores than the ADHD group. Subtests 
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Block Design and Mazes discriminated best. It was concluded that based on intelligence 
scores, only PDD-NOS and ADHD emerged as distinct categories, whereas the combined 
diagnosis did not. Allen et al. (2001) compared 18 preschool children with PDD-NOS to 176 
children with autistic disorder and 311 non-autistic children with developmental language 
disorders (DLD) (N = 201) or low IQ (N = 110). The children with PDD-NOS did not differ 
significantly from either the children with autism or the children with DLD in verbal and 
adaptive skills. They suggested that the similarity of PDD-NOS children to autistic children 
in maladaptive behaviors and an intermediate position between autistic and DLD groups on 
virtually all measures helped to explain the difficulty clinicians encounter in classifying 
children with PDD-NOS (Allen et al., 2001). 
Rates of comorbid psychiatric conditions in children with PDD-NOS are hardly available, 
although these conditions are often considered as more responsive to treatment than the 
core symptoms of PDD-NOS (deBruin  et al., 2007). In our sample (Karabekiroglu & Akbas, 
in press), 53.2% of the children with PDD-NOS had at least one co-morbid psychiatric 
disorder, including disruptive behavior disorders (40.4%), and anxiety disorders (18.0%). 
With respect to the PDD-NOS group, the ADHD group had significantly higher rates of co-
morbid disruptive behavior disorders, learning disabilities, tic disorders, elimination 
disorders, and social anxiety disorder. On the other hand, the PDD-NOS group had 
significantly higher rates of co-morbid obsessive compulsive disorder with respect to the 
ADHD group. In a previous study, DeBurin et al. (2007) explored the comorbidity in ninety-
four children with PDD-NOS, aged 6-12 years. At least one co-morbid psychiatric disorder 
was present in 80.9% of the children; 61.7% had a co-morbid disruptive behavior disorder, 
and 55.3% fulfilled criteria of an anxiety disorder. Compared to those without co-morbid 
psychiatric disorders, children with a co-morbid disorder had more deficits in social 
communication.  
5. Conclusion 
The overall results suggest that children with PDD-NOS have a high number of common 
features with patients having autism and ADHD. The symptoms of all three diagnostic 
groups appeared to form three clusters, “autistic spectrum,” “ADHD spectrum,” and 
“anxiety spectrum.” Many features including language and motor development, 
“presenting” and/or “reported” symptom distribution, and gender distribution were found 
to be similar in the PDD-NOS and the autism groups. Mental retardation rate and symptom 
severity (e.g., “poor social interaction”, “lack of eye contact”, “stereotypies”) were 
significantly higher in the autism group with respect to the PDD-NOS group. In addition, 
most of the previous studies supported quantitative discrimination rather than assuming 
that PDD-NOS and autism are qualitatively discrete groups. Therefore, PDD-NOS may be 
assumed as a partial subtype of autism and that it lies on a continuum of social-
communication skill deficits. On the other hand, some of the studies suggest that these 
individuals appear to have a distinct variant of autism that does not merely sit at the less 
severe end of the same continuum of symptoms. They emphasize that compared to other 
disorders in PDD category, the children diagnosed with PDD-NOS had comparably severe 
but more circumscribed social communication difficulties, with fewer non-social features of 
autism. Therefore, we still need to investigate further the clinical features of children with 
PDD-NOS that distinguish them from children with autism and other non-PDD conditions. 
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